Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1.296 INR | +0,29 % | -4,43 % | -4,43 % |
Resumen de negocios
Número de empleados: 1 642
Ventas por actividad
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 12 694 | 100,0 % | 14 667 | 100,0 % | +15,54 % |
Ventas por región
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Latin America
83,0
%
| 11 381 | 87,0 % | 12 638 | 83,0 % | +11,05 % |
United States
14,0
%
| 1 308 | 10,0 % | 2 132 | 14,0 % | +62,96 % |
Africa
3,0
%
| 392 | 3,0 % | 457 | 3,0 % | +16,40 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28/03/15 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 19/02/16 |
Anto V.
ADM | Chief Administrative Officer | - | - |
Gunasakaran S.
CTO | Chief Tech/Sci/R&D Officer | - | - |
Umesh Setty V.
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 25/06/22 | |
Chief Operating Officer | - | 01/12/10 | |
Umapathy V.
LAW | General Counsel | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 71 | - | |
Chief Operating Officer | - | 01/12/10 | |
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28/03/15 |
Director/Board Member | 64 | 09/11/16 | |
C. K. Gariyali
BRD | Director/Board Member | 75 | 04/03/20 |
R. Nagendran
BRD | Director/Board Member | - | - |
S Deenadhayalan
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 75 941 746 | 19 238 423 ( 25,33 %) | 0 | 25,33 % |
Información de la empresa
Caplin Point Laboratories Ltd.
Ashvich Tower Developed Plots Industrial Estate
600096, Chennai
+91 44 2496 8000
http://www.caplinpoint.netEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Caplin Steriles Ltd.
Caplin Steriles Ltd. Pharmaceuticals: MajorHealth Technology Caplin Steriles Ltd. manufactures and sells injectable pharmaceutical products. The company was founded on December 12, 2018 and is headquartered in Chennai, India. |
Pharmaceuticals: Major
|
Caplin Onco Ltd.
|
Sector
Ventas por región
Revisiones del BPA
Ganancias trimestrales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-4,43 % | 1176,13 M | |
+20,83 % | 43,57 mil M | |
+20,70 % | 22,7 mil M | |
+16,41 % | 14,32 mil M | |
+11,11 % | 13,42 mil M | |
+45,91 % | 11,83 mil M | |
-8,84 % | 6984,58 M | |
-0,05 % | 6787,61 M | |
-8,87 % | 5725,52 M | |
+12,41 % | 5510,42 M |
- Bolsa de valores
- Acciones
- Acción CAPLIPOINT
- Empresa Caplin Point Laboratories Limited